PROTAC B-Raf degrader 1
Product Specifications
UNSPSC Description
PROTAC B-Raf degrader 1 (compound 2) is a proteolysis targeting chimera (PROTAC) for the degradation of B-Raf based on Cereblon ligand with anti-cancer activity[1].
Target Antigen
PROTACs; Raf
Type
Reference compound
Related Pathways
MAPK/ERK Pathway;PROTAC
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/PROTAC_B-Raf_degrader_1.html
Purity
99.78
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC=CC(C(N2C(CC3)C(NC3=O)=O)=O)=C1C2=O)CNC(CNC4=CC(CS(=O)(/C=C/C5=C(OC)C=C(OC)C=C5OC)=O)=CC=C4OC)=O
Molecular Weight
763.77
References & Citations
[1]Chen H, et al. Pomalidomide hybrids act as proteolysis targeting chimeras: Synthesis, anticancer activity and B-Raf degradation. Bioorg Chem. 2019 Mar 19;87:191-199.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-111758/PROTAC-B-Raf-degrader-1-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-111758/PROTAC-B-Raf-degrader-1-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2364367-27-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ARP37038_P050-HRP 100 µL
Esr2 Antibody - N-terminal region: HRP (ARP37038_P050-HRP)
Ask
View Details 
